Muslih ÜRÜN, Gürkan GÜNER, Yasin SEZGİN, Emre UYSAL, Yonca YILMAZ ÜRÜN, Abdullah SAKİN
175-181
Metastatic gastric cancer, second-line chemotherapy, prognostic factor
Muslih ÜRÜN, Gürkan GÜNER, Yasin SEZGİN, Emre UYSAL, Yonca YILMAZ ÜRÜN, Abdullah SAKİN
Turkish Journal of Agriculture and Forestry
Inflamasyon ilişkili indeksler, palyatif bakım hastalarında kötü prognozu tanımlayabilir mi?
Journal of Contemporary Medicine
Ufuk ÜNLÜ, Nagihan YILDIZ ÇELTEK
Can Modified Dukes' Classification be Used in Gastric Cancer Staging?
Turkish Journal of Medical Sciences
Triumph or tragedy: progress in cancer
Ayşe Şebnem ERENLER, Hikmet GEÇKİL
In vitro antiproliferative/cytotoxic activity of 2,3'-biindole against various cancer cell lines
Salih ÖKTEN, Ramazan ERENLER, Tuğba KUL KÖPRÜLÜ, Şaban TEKİN
Circulating levels of IGF-I and IGFBP-3 in gastric cancer
Turkish Journal of Medical Sciences
Konca ALTINKAYNAK, Memet BİLİCİ, Nuri BAKAN, Fatih AKÇAY
Serum VEGF levels in gastric cancer patients: correlation with clinicopathological parameters